1-236747790-C-T
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_001103.4(ACTN2):c.1515+15C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000265 in 1,571,106 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_001103.4 intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ACTN2 | NM_001103.4 | c.1515+15C>T | intron_variant | Intron 13 of 20 | ENST00000366578.6 | NP_001094.1 | ||
ACTN2 | NM_001278343.2 | c.1515+15C>T | intron_variant | Intron 13 of 20 | NP_001265272.1 | |||
ACTN2 | NR_184402.1 | n.1887+15C>T | intron_variant | Intron 15 of 22 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00130 AC: 198AN: 152118Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000393 AC: 97AN: 246568Hom.: 0 AF XY: 0.000285 AC XY: 38AN XY: 133280
GnomAD4 exome AF: 0.000154 AC: 219AN: 1418870Hom.: 0 Cov.: 24 AF XY: 0.000126 AC XY: 89AN XY: 708196
GnomAD4 genome AF: 0.00130 AC: 198AN: 152236Hom.: 0 Cov.: 32 AF XY: 0.00128 AC XY: 95AN XY: 74442
ClinVar
Submissions by phenotype
not specified Benign:5
c.1515+15C>T in Intron 13 of ACTN2: This variant is not expected to have clinica l significance because it is not located within the splice consensus sequence an d has been identified in 0.4% (15/3738) of African American chromosomes from a b road population by the NHLBI Exome Sequencing Project (http://evs.gs.washington. edu/EVS;). -
This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Variant summary: ACTN2 c.1515+15C>T alters a non-conserved nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. 4/4 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.0005 in 277962 control chromosomes, predominantly at a frequency of 0.0053 within the African or African-American subpopulation in the gnomAD database. The observed variant frequency within African or African-American control individuals in the gnomAD database is approximately 212 fold of the estimated maximal expected allele frequency for a pathogenic variant in ACTN2 causing Cardiomyopathy phenotype (2.5e-05), strongly suggesting that the variant is a benign polymorphism found primarily in populations of African or African-American origin. To our knowledge, no occurrence of c.1515+15C>T in individuals affected with Cardiomyopathy and no experimental evidence demonstrating its impact on protein function have been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as benign. -
- -
- -
Primary familial hypertrophic cardiomyopathy;C2677338:Dilated cardiomyopathy 1AA Benign:1
- -
Dilated cardiomyopathy 1AA;C5203349:Myopathy, distal, 6, adult-onset, autosomal dominant;C5231445:Myopathy, congenital, with structured cores and z-line abnormalities Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at